ExodusPoint Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $871K | Buy |
+2,878
| New | +$871K | 0.01% | 940 |
|
|
2024
Q4 | – | Sell |
-2,645
| Closed | -$561K | – | 1709 |
|
|
2024
Q3 | $561K | Buy |
+2,645
| New | +$561K | ﹤0.01% | 1080 |
|
|
2023
Q4 | – | Sell |
-8,162
| Closed | -$1.19M | – | 1744 |
|
|
2023
Q3 | $1.19M | Buy |
+8,162
| New | +$1.19M | 0.01% | 863 |
|
|
2023
Q2 | – | Sell |
-1,060
| Closed | -$257K | – | 1994 |
|
|
2023
Q1 | $257K | Buy |
+1,060
| New | +$257K | ﹤0.01% | 1415 |
|
|
2022
Q4 | – | Sell |
-9,177
| Closed | -$596K | – | 1865 |
|
|
2022
Q3 | $596K | Buy |
9,177
+5,388
| +142% | +$350K | 0.01% | 1271 |
|
|
2022
Q2 | $271K | Buy |
+3,789
| New | +$271K | ﹤0.01% | 1518 |
|
|
2020
Q4 | – | Sell |
-2,089
| Closed | -$248K | – | 2128 |
|
|
2020
Q3 | $248K | Buy |
+2,089
| New | +$248K | ﹤0.01% | 1318 |
|